From: Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype
Age | 55 ± 12 |
Male gender | 134 (47) |
Family history of psoriasis (n = 280) | 175 (63) |
Family history of PsA (n = 280) | 45 (16) |
Age of onset of psoriasis | 28 ± 14 |
Psoriasis duration (years) | 27 ± 14 |
Age of onset of PsA | 35 ± 13 |
PsA duration (years) | 19 ± 9 |
Years between psoriasis and PsA | 6 (0 to 14) |
Psoriasis before PsA | 184 (65) |
PsA before psoriasis | 45 (16) |
Psoriasis and PsA at same time | 52 (18) |
Nail disease | 244 (79) |
 Pitting | 96 (34) |
 Onycholysis | 155 (55) |
Peripheral arthritis | 280 (99) |
 Polyarthritis | 258 (91) |
 Oligoarthritis | 21 (8) |
Deformed joint count, if deformity | 6 (4 to 12) |
Enthesitisa | 97 (34) |
Dactylitisa | 150 (53) |
Sacroiliitisa | 71 (25) |
 Asymmetrica | 51 (18) |
 Symmetrica | 18 (6) |
Joint deformitya | 183 (65) |
Joint fusiona | 83 (29) |
Erosionsa (n = 281) | 123 (44) |
Osteolysisa (n = 281) | 41 (15) |
Current PASI | 1.2 (0.3 to 2.8) |
Max PASI | 3.8 (1.8 to 9.2) |
Plaque psoriasis only | 224 (79) |
Psoriasis, nonplaque | 59 (21) |
Uveitis | 9 (3) |
Total on TNFi | 176 (62) |
 Psoriasis requiring TNFi | 32 (11) |
 PsA requiring TNFi | 171 (60) |
Number of TNFi, if on TNFi | 1 (1 to 2; range 1 to 4) |
Number of DMARDs | 1 (1 to 2; range 0 to 5) |